Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |